These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17907547)

  • 1. [Prolonged diminished effect of coumarin derivatives after use of rifampicin].
    Harmsze AM; Deneer VH; Wiltink EH
    Ned Tijdschr Geneeskd; 2007 Sep; 151(35):1945-9. PubMed ID: 17907547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems in anticoagulation of a patient with antibiotic treatment for endocarditis: interaction of rifampicin and vitamin K antagonists.
    Mizera L; Geisler T; Mörike K; Gawaz M; Steeg M
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants.
    Visser LE; Penning-van Beest FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
    Clin Pharmacol Ther; 2002 Jun; 71(6):496-502. PubMed ID: 12087353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants.
    Visser LE; Bleumink GS; Trienekens PH; Vulto AG; Hofman A; Stricker BH
    Br J Haematol; 2004 Oct; 127(1):85-9. PubMed ID: 15384981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and clinical significance of amiodarone and acenocoumarol interaction.
    Caraco Y; Chajek-Shaul T
    Thromb Haemost; 1989 Nov; 62(3):906-8. PubMed ID: 2595664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.
    Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miconazole oral gel enhances acenocoumarol anticoagulant activity: a report of three cases.
    Ortín M; Olalla JI; Muruzábal MJ; Peralta FG; Gutiérrez MA
    Ann Pharmacother; 1999 Feb; 33(2):175-7. PubMed ID: 10084413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Knowledge of patients undergoing long-term acenocumarol treatment about the safety of anticoagulant therapy].
    Sawicka-Powierza J; Ołtarzewska AM; Chlabicz S
    Pol Merkur Lekarski; 2007 Jan; 22(127):36-40. PubMed ID: 17477088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements.
    van Geest-Daalderop JH; Péquériaux NC; van den Besselaar AM
    Thromb Haemost; 2009 Sep; 102(3):588-92. PubMed ID: 19718481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services].
    van Geest-Daalderop JH; Sturk A; Levi M; Adriaansen HJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(15):730-5. PubMed ID: 15119208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect.
    Hasan SA
    Cornea; 2007 Jul; 26(6):742-3. PubMed ID: 17592328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A patient with lessened sensitivity to acenocoumarol during a period of enteral feeding].
    van Iersel MD; Blenke AA; Kremer HP; Hekster YA
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1155-7. PubMed ID: 15211967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy.
    Vreeburg EM; De Vlaam-Schluter GM; Trienekens PH; Snel P; Tytgat GN
    Scand J Gastroenterol; 1997 Oct; 32(10):991-4. PubMed ID: 9361171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.